Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Group Representing Amazon.com, Newspapers, eBay, Greeting Card Companies Opposes Planned U.S. Postal Service Price Increase

-Reuters

byBenzinga Newsdesk

June 4, 2021

1 minute read

-Reuters

Xponential Partners With Lululemon On Smart Home Gym Offering

By Shivani Kumaresan

Today, 8:04 PM

Xponential Fitness Inc (NYSE:XPOF) has partnered with Lululemon Athletica Inc (NASDAQ:LULU) to create original fitness programming for the Mirror, the retailer’s smart home…

LULU

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 8:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

Science 37 Sees FY23 Revenue Guidance Of $55M-$60M Vs. $73.66M Estimate

By Benzinga Newsdesk

Today, 8:04 PM

The company expects adjusted EBITDA guidance of $(50.0) million to $(48.0) million.

SNCE

Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish Line

By Vandana Singh

Today, 8:04 PM

Apellis Pharmaceuticals Inc’s (NASDAQ:APLS) pegcetacoplan posted mixed results in two Phase 3 trials in 1,258 geographic atrophy (GA). Despite the mixed…

APLS

Group Representing Amazon.com, Newspapers, eBay, Greeting Card Companies Opposes Planned U.S. Postal Service Price Increase

Related Posts

Xponential Partners With Lululemon On Smart Home Gym Offering

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

Science 37 Sees FY23 Revenue Guidance Of $55M-$60M Vs. $73.66M Estimate

Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish Line